Anticoagulant-induced changes on antibiotic concentrations in the serum and bones
Summary The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy ma...
Gespeichert in:
Veröffentlicht in: | European journal of drug metabolism and pharmacokinetics 2008-07, Vol.33 (3), p.173-179 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 179 |
---|---|
container_issue | 3 |
container_start_page | 173 |
container_title | European journal of drug metabolism and pharmacokinetics |
container_volume | 33 |
creator | Kotsiou, A. Diamanti, E. Potamianou, A. Parara, H. Vovou, J. Perisanidis, C. Tesseromatis, C. |
description | Summary
The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14
g
were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin
via
1 g/kg/8h im injection. Group II received cefapirin
via
of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice. |
doi_str_mv | 10.1007/BF03191115 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF03191115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19007043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-c68a7ecfe34d8bde00b210e7fbc52496acc1eb50b206c4b79191072fe7fe28543</originalsourceid><addsrcrecordid>eNpt0M9PwyAUB3BiNG6Zu_gHGC5eNNVHKaU9zsVfyRJjoucGXunGssEC7cH_XpYt7iIXkscHHu9LyDWDBwYgH59egLOaMSbOyDhnIDNgFZyTMXBZZbIuyxGZxriGtHhVC1FekhGr01Uo-Jh8zlxv0avlsFGuz6xrBzQtxZVySxOpdzSVrbY-KYreoXF9UL31LlLraL8yNJowbBNrqfbOxCty0alNNNPjPiHfL89f87ds8fH6Pp8tMuQM-gzLSkmDneFFW-nWAOj0eyM7jSIv6lIhMqNFqkKJhZZ1GhJk3iVh8koUfELuDu9i8DEG0zW7YLcq_DQMmn00zSmahG8OeDforWlP9BhEArdHoCKqTReUQxv_XA6yKgXfu_uDi-koRRSatR-CS4P-1_YXN8p5EA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Kotsiou, A. ; Diamanti, E. ; Potamianou, A. ; Parara, H. ; Vovou, J. ; Perisanidis, C. ; Tesseromatis, C.</creator><creatorcontrib>Kotsiou, A. ; Diamanti, E. ; Potamianou, A. ; Parara, H. ; Vovou, J. ; Perisanidis, C. ; Tesseromatis, C.</creatorcontrib><description>Summary
The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14
g
were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin
via
1 g/kg/8h im injection. Group II received cefapirin
via
of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.</description><identifier>ISSN: 0378-7966</identifier><identifier>EISSN: 2107-0180</identifier><identifier>DOI: 10.1007/BF03191115</identifier><identifier>PMID: 19007043</identifier><language>eng</language><publisher>Paris: Springer-Verlag</publisher><subject>Acenocoumarol - pharmacology ; Administration, Oral ; Animals ; Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - pharmacokinetics ; Anticoagulants - pharmacology ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Drug Interactions ; Femur - chemistry ; Human Physiology ; Injections, Intramuscular ; Male ; Mandible - chemistry ; Medical Biochemistry ; Medical sciences ; Pharmaceutical Sciences/Technology ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Pharmacy ; Prothrombin Time ; Quinolones - blood ; Quinolones - pharmacokinetics ; Rats ; Rats, Wistar ; Tissue Distribution</subject><ispartof>European journal of drug metabolism and pharmacokinetics, 2008-07, Vol.33 (3), p.173-179</ispartof><rights>Springer-Verlag 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-c68a7ecfe34d8bde00b210e7fbc52496acc1eb50b206c4b79191072fe7fe28543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/BF03191115$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/BF03191115$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20786533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19007043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kotsiou, A.</creatorcontrib><creatorcontrib>Diamanti, E.</creatorcontrib><creatorcontrib>Potamianou, A.</creatorcontrib><creatorcontrib>Parara, H.</creatorcontrib><creatorcontrib>Vovou, J.</creatorcontrib><creatorcontrib>Perisanidis, C.</creatorcontrib><creatorcontrib>Tesseromatis, C.</creatorcontrib><title>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</title><title>European journal of drug metabolism and pharmacokinetics</title><addtitle>Eur. J. Drug Metabol. Pharmacokinet</addtitle><addtitle>Eur J Drug Metab Pharmacokinet</addtitle><description>Summary
The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14
g
were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin
via
1 g/kg/8h im injection. Group II received cefapirin
via
of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.</description><subject>Acenocoumarol - pharmacology</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anticoagulants - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Drug Interactions</subject><subject>Femur - chemistry</subject><subject>Human Physiology</subject><subject>Injections, Intramuscular</subject><subject>Male</subject><subject>Mandible - chemistry</subject><subject>Medical Biochemistry</subject><subject>Medical sciences</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Prothrombin Time</subject><subject>Quinolones - blood</subject><subject>Quinolones - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Tissue Distribution</subject><issn>0378-7966</issn><issn>2107-0180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0M9PwyAUB3BiNG6Zu_gHGC5eNNVHKaU9zsVfyRJjoucGXunGssEC7cH_XpYt7iIXkscHHu9LyDWDBwYgH59egLOaMSbOyDhnIDNgFZyTMXBZZbIuyxGZxriGtHhVC1FekhGr01Uo-Jh8zlxv0avlsFGuz6xrBzQtxZVySxOpdzSVrbY-KYreoXF9UL31LlLraL8yNJowbBNrqfbOxCty0alNNNPjPiHfL89f87ds8fH6Pp8tMuQM-gzLSkmDneFFW-nWAOj0eyM7jSIv6lIhMqNFqkKJhZZ1GhJk3iVh8koUfELuDu9i8DEG0zW7YLcq_DQMmn00zSmahG8OeDforWlP9BhEArdHoCKqTReUQxv_XA6yKgXfu_uDi-koRRSatR-CS4P-1_YXN8p5EA</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>Kotsiou, A.</creator><creator>Diamanti, E.</creator><creator>Potamianou, A.</creator><creator>Parara, H.</creator><creator>Vovou, J.</creator><creator>Perisanidis, C.</creator><creator>Tesseromatis, C.</creator><general>Springer-Verlag</general><general>Médecine et hygiène</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080701</creationdate><title>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</title><author>Kotsiou, A. ; Diamanti, E. ; Potamianou, A. ; Parara, H. ; Vovou, J. ; Perisanidis, C. ; Tesseromatis, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-c68a7ecfe34d8bde00b210e7fbc52496acc1eb50b206c4b79191072fe7fe28543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acenocoumarol - pharmacology</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anticoagulants - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Drug Interactions</topic><topic>Femur - chemistry</topic><topic>Human Physiology</topic><topic>Injections, Intramuscular</topic><topic>Male</topic><topic>Mandible - chemistry</topic><topic>Medical Biochemistry</topic><topic>Medical sciences</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Prothrombin Time</topic><topic>Quinolones - blood</topic><topic>Quinolones - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kotsiou, A.</creatorcontrib><creatorcontrib>Diamanti, E.</creatorcontrib><creatorcontrib>Potamianou, A.</creatorcontrib><creatorcontrib>Parara, H.</creatorcontrib><creatorcontrib>Vovou, J.</creatorcontrib><creatorcontrib>Perisanidis, C.</creatorcontrib><creatorcontrib>Tesseromatis, C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of drug metabolism and pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kotsiou, A.</au><au>Diamanti, E.</au><au>Potamianou, A.</au><au>Parara, H.</au><au>Vovou, J.</au><au>Perisanidis, C.</au><au>Tesseromatis, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticoagulant-induced changes on antibiotic concentrations in the serum and bones</atitle><jtitle>European journal of drug metabolism and pharmacokinetics</jtitle><stitle>Eur. J. Drug Metabol. Pharmacokinet</stitle><addtitle>Eur J Drug Metab Pharmacokinet</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>33</volume><issue>3</issue><spage>173</spage><epage>179</epage><pages>173-179</pages><issn>0378-7966</issn><eissn>2107-0180</eissn><abstract>Summary
The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones i.e. cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8–10 weeks and weighed 170±14
g
were used and divided into seven groups (I, II, III, IV, V, VI, VII: n= 10). The rats in group I received cefapirin
via
1 g/kg/8h im injection. Group II received cefapirin
via
of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18mg/kg/24h im and 0,1 mg/kg/24h p.o. acenocoumarin. Group V received 10mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and. 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.</abstract><cop>Paris</cop><pub>Springer-Verlag</pub><pmid>19007043</pmid><doi>10.1007/BF03191115</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-7966 |
ispartof | European journal of drug metabolism and pharmacokinetics, 2008-07, Vol.33 (3), p.173-179 |
issn | 0378-7966 2107-0180 |
language | eng |
recordid | cdi_crossref_primary_10_1007_BF03191115 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Acenocoumarol - pharmacology Administration, Oral Animals Anti-Bacterial Agents - blood Anti-Bacterial Agents - pharmacokinetics Anticoagulants - pharmacology Biological and medical sciences Biomedical and Life Sciences Biomedicine Drug Interactions Femur - chemistry Human Physiology Injections, Intramuscular Male Mandible - chemistry Medical Biochemistry Medical sciences Pharmaceutical Sciences/Technology Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacy Prothrombin Time Quinolones - blood Quinolones - pharmacokinetics Rats Rats, Wistar Tissue Distribution |
title | Anticoagulant-induced changes on antibiotic concentrations in the serum and bones |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T11%3A47%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticoagulant-induced%20changes%20on%20antibiotic%20concentrations%20in%20the%20serum%20and%20bones&rft.jtitle=European%20journal%20of%20drug%20metabolism%20and%20pharmacokinetics&rft.au=Kotsiou,%20A.&rft.date=2008-07-01&rft.volume=33&rft.issue=3&rft.spage=173&rft.epage=179&rft.pages=173-179&rft.issn=0378-7966&rft.eissn=2107-0180&rft_id=info:doi/10.1007/BF03191115&rft_dat=%3Cpubmed_cross%3E19007043%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19007043&rfr_iscdi=true |